Pharma Logistics to CIS Countries from India: Routes, Documents and Transit Planning

Pharma logistics from India to CIS countries requires much more planning than standard international cargo movement. Pharmaceutical exporters have to manage freight booking, Indian export customs, temperature requirements, shipment documentation, destination regulations, transit connections and final delivery as one continuous supply chain.

India exported more than US$30 billion worth of pharmaceutical products during FY2024-25, with exports reaching more than 190 countries. Russia, Kazakhstan, Uzbekistan and other CIS markets continue to offer opportunities for Indian pharmaceutical manufacturers, formulation companies and API exporters.

For urgent, high-value and temperature-sensitive medicines, air freight is generally the preferred option because it reduces the amount of time cargo remains in transit. For larger shipments of stable pharmaceutical products, sea freight and multimodal transport may offer better economics.

Transit time can vary significantly. Air freight between India and major Central Asian destinations can take around 3 to 7 days depending on the route, flight connection and customs clearance. Sea and multimodal shipments to landlocked markets may require approximately 30 to 50 days.

The right transport option depends on several factors:

• Required temperature range
• Shipment value
• Remaining shelf life
• Required delivery date

A pharmaceutical exporter should therefore compare the complete door-to-door route rather than choosing a shipment based only on the lowest freight rate.

Why Pharma Shipping to CIS Countries Requires Detailed Route Planning

CIS pharmaceutical logistics cannot be treated as one standard freight lane. Russia, Uzbekistan, Kazakhstan, Belarus, Armenia, Kyrgyzstan and other markets have different transport corridors, airport connectivity, customs processes and inland delivery requirements.

A shipment from Hyderabad to Moscow may travel entirely by air with one international connection, while another shipment from Mumbai to Uzbekistan may move by sea to Iran and then continue by road through Central Asia.

The operational risk increases every time cargo changes hands.

A typical pharmaceutical shipment may pass through 7 to 10 physical handling stages before reaching the final buyer. These can include manufacturer dispatch, refrigerated pickup, airport terminal handling, customs inspection, airline loading, international transit, destination terminal handling, customs clearance and final delivery.

For temperature-controlled cargo, every transfer matters.

A product requiring +2°C to +8°C storage may remain inside a validated thermal shipper for several days, but unexpected delays at a transit airport can reduce the available protection window. A 12-hour connection that turns into a 36-hour delay can create a completely different temperature risk.

This is why route planning should examine:

• Number of transit points
• Cold storage availability
• Connection time
• Backup routing options

The safest pharmaceutical route is not always the shortest route on a map. In many cases, a route with one reliable transit hub can be operationally better than a cheaper routing involving 2 or 3 cargo transfers.

Pharma Trade Between India and CIS Markets

India has built a strong pharmaceutical export base covering generic medicines, APIs, vaccines, medical products and specialty formulations.

India’s pharmaceutical exports crossed approximately US$30.47 billion in FY2024-25, recording close to 9.4% annual growth. The country exports pharmaceutical products to more than 190 international markets.

CIS countries form an important part of this export network.

Russia remains one of the largest pharmaceutical destinations in the region. Uzbekistan and Kazakhstan have also developed into important markets for Indian manufacturers because of growing demand for affordable generic medicines and pharmaceutical products.

For exporters, however, commercial demand is only one part of the opportunity. The logistics model must match each market.

Russia offers air, sea and multimodal options. Uzbekistan and Kazakhstan require stronger inland route planning because both are landlocked countries.

That difference affects freight cost, cargo handling and transit time.

A pharma exporter therefore needs to evaluate the destination at country level rather than requesting a generic “CIS freight rate.”

India to Russia Pharma Logistics

Russia can be served from India through air freight, ocean freight and multimodal transport corridors.

For urgent pharmaceutical shipments, air freight normally provides the most predictable transit window. Cargo can move from major Indian gateways such as Delhi, Mumbai and Hyderabad toward Russian airports depending on available carrier capacity and current flight connections.

Airport-to-airport movement can sometimes be completed in 1 to 3 days, but total door-to-door movement usually takes longer because origin pickup, Indian customs, terminal acceptance, destination customs and delivery also need to be included.

For non-urgent commercial volumes, ocean and multimodal routes can be evaluated.

Several trade corridors connect India with Russia through ports and inland networks. The International North-South Transport Corridor has become particularly important because it links India with Iran, Central Asia and Russia.

Recent corridor developments have demonstrated transit benchmarks of around 16 days on certain sections of the eastern North-South corridor, compared with around 33 days earlier.

However, exporters should not assume that every India to Russia pharma shipment will arrive in 16 days.

Actual door-to-door transit can vary based on:

• Indian origin location
• Port connection
• Iran transit
• Border movement

For pharmaceutical products, longer multimodal routes should be considered only when product stability, packaging validation and commercial delivery schedules can support the additional transit exposure.

India to Uzbekistan Pharma Logistics

Uzbekistan is one of the most interesting pharmaceutical logistics markets in Central Asia because Indian pharmaceutical products have a strong presence in the country.

The main challenge is geography.

Uzbekistan does not have direct sea access. This means that sea freight cannot reach the country without an additional road or rail leg.

Air freight is therefore commonly used for urgent pharmaceutical shipments.

Cargo can move from Indian airports such as Delhi or Mumbai toward Tashkent. Depending on the airline, connection and destination customs process, indicative transit may be around 3 to 7 days.

This option can work well for urgent finished formulations, high-value medicines, small API shipments and temperature-sensitive cargo.

For larger commercial quantities, sea and multimodal transport may offer lower cost.

A typical multimodal movement may involve an Indian west coast port such as Nhava Sheva or Mundra, followed by ocean transport to Bandar Abbas in Iran and onward movement through road or rail networks toward Uzbekistan.

Total transit can reach approximately 30 to 50 days.

That means inventory could remain in the logistics chain for almost 1 month longer than an air shipment.

For pharmaceutical exporters, this difference should be included in working capital and inventory planning.

India to Kazakhstan Pharma Logistics

Kazakhstan is another major Central Asian destination where pharmaceutical logistics requires careful route selection.

Air freight is generally suitable for urgent, high-value or temperature-controlled shipments. Cargo may move from Delhi, Mumbai or other international Indian gateways toward Almaty or Astana depending on airline schedules.

Multimodal alternatives can also be considered for larger commercial shipments.

A real pharma movement from Mumbai to Almaty through Baku demonstrated that pharmaceutical cargo requiring +15°C to +25°C conditions could be transported through a multimodal corridor while maintaining controlled temperature throughout the journey.

This type of movement requires more than a refrigerated truck.

The supply chain needs temperature data loggers, thermal protection, handling instructions, verified storage points and clear responsibility during every transfer.

For Kazakhstan shipments, exporters should compare:

• Direct or connecting air options
• Transit hub quality
• Inland delivery distance
• Product temperature requirement

A 15-day cheaper route may not be commercially better if it introduces multiple uncontrolled handovers.

Air Freight vs Sea and Multimodal Pharma Shipping

Air freight and multimodal freight serve very different pharmaceutical supply-chain needs.

Air freight is generally used when speed, product value and risk reduction are more important than freight cost. It is commonly preferred for urgent finished formulations, vaccines, biologics, trial material and products with limited remaining shelf life.

Sea and multimodal transport can make more sense when shipment volume is large and the product can tolerate a longer transit window.

The cost difference can be significant, but transport cost should never be evaluated in isolation.

Consider a shipment valued at ₹50 lakh.

If air freight costs ₹3 lakh more than multimodal transport but reduces transit by 25 days, the exporter should compare that ₹3 lakh difference against the value of inventory being held in transit for nearly 1 additional month.

For recurring pharmaceutical supply chains, many exporters use a mixed model.

Regular base inventory moves through lower-cost sea or multimodal freight, while urgent replenishment moves by air.

Factor	Air Freight	Sea / Multimodal
Typical speed	3-7 days on many CIS lanes	20-50+ days
High-value cargo	Strong fit	Requires assessment
+2°C to +8°C products	Usually preferred	Requires qualified solution
Large commercial volumes	Expensive	Often economical
Number of handovers	Lower	Usually higher
Inventory exposure	Lower	Higher
Urgent replenishment	Strong fit	Weak fit

The best mode depends on the product, not simply the price per kilogram.

Step-by-Step Pharma Export Logistics Process from India

A pharmaceutical shipment should be planned before the cargo leaves the manufacturer’s facility.

The first stage is shipment assessment.

The exporter or logistics team should provide the product description, HS code, shipment weight, dimensions, number of packages, temperature range, cargo value, destination and required delivery date.

If the shipment requires temperature control, the logistics team should also know how long the packaging system is validated to maintain the required range.

The second stage is route and carrier selection.

Airline or shipping capacity is checked, transit points are evaluated and origin pickup is planned. For temperature-controlled cargo, refrigerated transport may be required between the manufacturer’s warehouse and the airport.

The third stage is documentation preparation and Indian export customs.

The Shipping Bill is filed electronically through India’s customs system. The commercial invoice, packing list and other supporting documents must match the shipment details.

If Customs selects the shipment for examination or requests clarification, additional time may be required.

After Customs issues the Let Export Order, the shipment still needs to complete terminal acceptance and carrier loading.

This is important because customs clearance does not automatically mean cargo departs immediately.

The final stages include international transport, destination customs clearance and delivery to the importer.

Stage	Activity	Typical Risk
Planning	Route and temperature assessment	Incorrect mode selection
Booking	Airline or carrier confirmation	Space shortage
Pickup	Manufacturer to gateway	Temperature excursion
Customs	Shipping Bill and clearance	Documentation query
Terminal	Cargo acceptance	Missed cut-off
International transport	Main freight movement	Connection delay
Destination customs	Import clearance	Regulatory hold
Delivery	Final consignee movement	Last-mile exposure

Every stage should have a responsible party and escalation plan.

Documents Required for Pharmaceutical Exports from India

Documentation is one of the most common reasons international pharma shipments are delayed.

A basic commercial shipment normally requires a Commercial Invoice, Packing List, Shipping Bill and Airway Bill or Bill of Lading.

Pharmaceutical cargo can require additional documents depending on the product and destination market.

For example, an importer may require Certificate of Analysis, batch details, manufacturer documents, Certificate of Origin, product registration information or destination import approval.

The exact requirement must be confirmed for the importing country.

Russia, Kazakhstan and Uzbekistan should not be treated as if they follow identical pharmaceutical import procedures.

The commercial invoice is particularly important because product description, value, consignee information and HS classification should remain consistent across customs and transport documentation.

Even small differences can create questions at destination.

Document	Purpose	Risk if Incorrect
Commercial Invoice	Declares cargo value and transaction	Customs query
Packing List	Shows quantity, weight and packages	Cargo mismatch
Shipping Bill	Indian export declaration	Export delay
Airway Bill / Bill of Lading	Transport document	Routing issue
Certificate of Origin	Confirms origin where required	Clearance issue
Certificate of Analysis	Product quality information	Regulatory delay
Batch documents	Product traceability	Importer query
Import approval	Destination compliance	Cargo hold

Before dispatch, the exporter should ensure that origin documentation and destination import documentation are aligned.

Temperature-Controlled Pharma Logistics from India

Temperature control is one of the most sensitive parts of pharmaceutical logistics.

Products may require +2°C to +8°C, +15°C to +25°C, frozen or other defined storage conditions.

The required range should come from the product manufacturer and stability data. The logistics provider should then design transport around that requirement.

One common mistake is assuming that using a thermal box automatically creates a compliant cold chain.

It does not.

The shipment may still face uncontrolled exposure during loading, customs examination, terminal movement, tarmac handling, transit connections and destination clearance.

A typical international pharma movement can spend 20 to 30 hours outside the aircraft even when actual flight time is only 6 to 8 hours.

That is why airport infrastructure matters.

Mumbai airport provides dedicated pharmaceutical handling facilities covering both +2°C to +8°C and +15°C to +25°C cargo.

The infrastructure includes temperature-controlled rooms, data monitoring and support for active temperature-controlled containers.

Hyderabad Airport has also strengthened pharma handling by introducing airside reefer movement designed to protect cargo between the terminal and the aircraft.

For exporters, the key planning questions should be:

• What temperature range must be maintained?
• How many hours is the packaging validated for?
• Is cold storage available at the transit airport?
• What happens if the connection is missed?

These questions are more important than simply asking whether the airline accepts pharma cargo.

How Long Does Export Customs Clearance Take in India?

Customs clearance is often misunderstood in freight planning.

Many exporters automatically assume that export customs takes 2 or 3 days.

Actual regulatory processing can be significantly faster when documentation is correct.

Recent Indian customs data showed average export regulatory clearance of less than 4 hours at major Air Cargo Complexes.

At seaports, average regulatory clearance was around 29 hours 36 minutes, while ICD export clearance was close to 30 hours.

However, this does not mean cargo will depart immediately after Customs clearance.

Post-clearance logistics can take much longer.

At seaports, average post-Let Export Order logistics time has been recorded at more than 157 hours, which is over 6 days.

This delay can include vessel planning, container movement, terminal operations and departure schedules.

At air cargo terminals, the difference is smaller but still important because airline cut-off times and cargo acceptance windows can affect departure.

For pharmaceutical exporters, total planning should therefore consider:

Customs time + terminal time + carrier waiting time + international transit + destination clearance.

Looking only at customs clearance can create an unrealistic delivery promise.

Pharma Logistics Cost Breakdown

There is no single fixed pharma freight rate from India to CIS countries.

Cost depends on origin, destination, shipment weight, cargo dimensions, temperature requirement, airline capacity, route and delivery location.

For air freight, the total cost may include factory pickup, refrigerated transport, packaging, airline freight, fuel surcharge, security surcharge, terminal handling, export documentation, customs brokerage, temperature monitoring, destination handling and final delivery.

Chargeable weight is also important.

A shipment weighing 300 kg may be charged at 450 kg if the volumetric weight is higher.

For temperature-controlled cargo, packaging can become a significant cost component.

A standard ambient pharmaceutical shipment may only require standard export packaging, while a +2°C to +8°C shipment may need validated passive packaging or an active temperature-controlled container.

For sea and multimodal shipments, cost components may include:

• Origin trucking
• Container charges
• Ocean freight
• Inland CIS movement

Additional costs may also arise from terminal handling, customs brokerage, reefer electricity, border processing and delivery.

The right comparison is therefore total door-to-door logistics cost, not only the airline rate or ocean freight rate.

Where Pharma Shipments Usually Get Delayed

Pharmaceutical shipments are often delayed by small operational mistakes rather than major international disruptions.

One of the most common problems is documentation mismatch.

If the commercial invoice describes the cargo differently from the Shipping Bill or destination documents, customs authorities may request clarification.

Another major issue is missing airline cut-off time.

A shipment can have complete customs clearance but still miss its planned flight because the cargo reaches terminal acceptance too late.

Transit connections are another risk.

Suppose a shipment is booked on Delhi to Almaty through an international hub with an 8-hour connection.

If the first flight is delayed by 5 hours, the shipment may miss the connecting aircraft. The next suitable flight may depart 24 hours later.

For standard cargo, this may simply increase transit time.

For temperature-controlled pharmaceuticals, the logistics team must immediately confirm storage temperature, remaining packaging validation time and the next available routing.

Destination documentation can create an even longer delay.

If the importer does not have the required registration or approval ready before cargo arrives, the shipment can remain inside the destination terminal while storage costs continue.

Good pharma logistics planning therefore starts before the cargo is booked.

The Real Cost of a Pharma Shipment Delay

A delay can cost much more than one extra day of storage.

Consider a pharmaceutical shipment worth ₹40 lakh.

If the cargo experiences a temperature excursion, the importer may place the entire shipment under quarantine.

The quality team may then need to review data logger records, stability information and product exposure before deciding whether the shipment can be released.

During this period, the shipment may continue generating storage costs.

If the product cannot be released, the exporter may also face replacement freight, product loss and customer claims.

For sea and reefer cargo, additional days can create terminal storage, reefer plug-in charges, detention or demurrage depending on the container and shipping line terms.

A shipment delayed by 5 days therefore cannot be evaluated only through a daily storage charge.

The bigger financial impact may come from lost sales, emergency replacement air freight and inventory shortage at the destination.

For this reason, logistics managers should compare the cost of prevention against the cost of failure.

Paying ₹50,000 more for a stronger routing may be commercially sensible if it protects cargo worth ₹50 lakh.

Choosing the Right Indian Airport or Port

The closest gateway is not always the best gateway for pharma cargo.

Delhi is important for exporters based in North India because of international connectivity and proximity to major manufacturing clusters.

Mumbai offers extensive international airline connectivity and dedicated pharma handling infrastructure.

Hyderabad is strategically important because of the large pharmaceutical manufacturing ecosystem in Telangana and nearby regions.

The airport decision should consider 5 factors:

• Flight frequency
• Temperature-control capability
• Transit options
• Cargo acceptance process

Another important factor is trucking distance.

A manufacturer located 150 km from Hyderabad may not benefit from moving cargo 700 km by road to another airport simply to save a small amount on air freight.

For sea freight, Mundra and JNPA are important western gateways.

JNPA handled more than 8 million TEUs during FY2025-26, demonstrating the scale of container movement available through India’s west coast.

However, volume alone should not determine gateway selection.

The best port is the one that connects efficiently with the required multimodal corridor and provides a manageable overall transit plan.

When Air Freight Makes More Commercial Sense

Air freight becomes commercially stronger when delay costs more than freight.

A shipment containing ₹1 crore worth of high-value pharmaceuticals does not need to be treated the same way as a low-value commodity shipment.

If air freight reduces transit from 35 days to 5 days, the exporter removes approximately 30 days of inventory exposure.

This can improve cash flow, reduce destination inventory requirements and help the importer react more quickly to demand.

Air freight can also reduce the number of border crossings and physical handovers.

That can be valuable for temperature-sensitive pharmaceutical products.

Air freight is especially suitable when:

• The cargo is urgent
• Product value is high
• Shelf life is limited
• Temperature sensitivity is high

The final decision should compare air freight cost against inventory carrying cost and commercial risk.

When Sea or Multimodal Freight Makes More Commercial Sense

Sea and multimodal freight becomes more attractive when pharmaceutical shipments are large, stable and planned in advance.

A manufacturer supplying regular commercial volumes to a CIS distributor may not need to move every shipment by air.

For example, a monthly replenishment programme can use slower multimodal transport for base inventory while keeping air freight available for urgent orders.

This creates a more balanced logistics model.

Product stability is important.

A +15°C to +25°C product with strong stability data may offer more flexibility than a highly sensitive +2°C to +8°C product.

Remaining shelf life also matters.

A shipment with 24 months of remaining shelf life may tolerate a 35-day transit more easily than one with only 6 months remaining.

Sea and multimodal transport works best when:

• Demand is predictable
• Shipment volume is large
• Shelf life is sufficient
• Destination inventory is planned

Cost savings should never come at the expense of product integrity.

Role of a Pharma Freight Forwarder

A pharma freight forwarder’s job is not simply to book an airline or container.

The first responsibility is understanding the shipment.

The forwarder should know the product, shipment dimensions, temperature range, required delivery date, destination, cargo value and regulatory requirements before recommending a route.

The second responsibility is route selection.

This includes choosing the Indian gateway, carrier, transit airport or port and destination delivery model.

The third responsibility is coordination.

An international pharma shipment may involve the manufacturer, transporter, customs broker, cargo terminal, airline, destination agent, importer and final delivery partner.

If even one party receives incomplete information, the shipment can be delayed.

A strong freight forwarder therefore manages the shipment as a chain rather than a collection of individual bookings.

This becomes especially important in CIS logistics where multiple international and inland transport legs may be involved.

How Pharmaceutical Exporters Should Plan Before Booking

Before requesting a freight quote, exporters should provide complete shipment information.

At minimum, the freight team should know the origin city, destination city, product type, shipment weight, dimensions, temperature requirement, cargo value and required delivery date.

For example:

A quote request saying “500 kg pharma cargo India to Kazakhstan” is not enough.

A useful request would say:

500 kg pharmaceutical formulations, 4 pallets, +15°C to +25°C, pickup from Baddi, delivery to Almaty, cargo ready September 20 and required delivery before September 28.

That information allows the logistics team to compare airport options, trucking time, airline connections and temperature requirements properly.

For temperature-controlled cargo, exporters should also confirm:

• Packaging validation period
• Data logger requirement
• Backup storage requirement
• Importer documentation status

Providing these details before booking can reduce last-minute operational changes.

Conclusion

Pharma logistics from India to CIS countries requires a combination of freight planning, customs management, temperature control and destination coordination.

Russia, Kazakhstan, Uzbekistan and other CIS markets cannot be treated as one standard shipping lane because each country has different transport options and inland requirements.

Air freight can reduce transit to a few days for many Central Asian routes, while sea and multimodal solutions may require 20 to 50 days depending on the destination.

The difference should be evaluated against product value, shelf life, temperature sensitivity and inventory planning.

Indian export customs can also move faster than many exporters expect. Average regulatory clearance at major air cargo complexes has been recorded at under 4 hours, but actual shipment departure can still be delayed by terminal operations, airline cut-offs and connections.

The best pharmaceutical logistics plan therefore begins before cargo reaches the airport.

Correct documents, realistic transit planning, temperature-qualified handling and the right transport mode can protect both the shipment and the buyer relationship.

Cargo People Logistics supports pharmaceutical exporters with air freight, sea freight, customs clearance, door-to-door delivery, warehousing and international shipment coordination from India to CIS markets.

📞 +91 97174 65454
📧 wecare@cargopeople.com

👉 Get a Shipping Quote from Cargo People Logistics

Frequently Asked Questions

1. How long does pharma shipping from India to CIS countries take?

Air freight commonly takes around 3 to 7 days on many Central Asian routes, depending on flight connections and customs. Sea and multimodal shipments may take 20 to 50 days or longer depending on the destination.

2. What documents are required for pharma exports from India?

Common documents include the Commercial Invoice, Packing List, Shipping Bill and Airway Bill or Bill of Lading. Additional pharmaceutical and destination-specific documents may also be required.

3. Can +2°C to +8°C medicines be shipped from India to CIS countries?

Yes. Suitable cold-chain packaging, temperature-controlled storage, monitoring and route planning are required throughout the movement.

4. Is air freight better for pharma shipments?

Air freight is normally more suitable for urgent, high-value and temperature-sensitive pharmaceutical products. Larger planned shipments may be more economical through sea or multimodal transport.

5. Which Indian airports are commonly used for pharmaceutical exports?

Delhi, Mumbai and Hyderabad are important pharmaceutical cargo gateways. The best airport depends on origin, airline connectivity, transit route and cold-chain infrastructure.